220 related articles for article (PubMed ID: 29779223)
1. Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission.
Peng C; Yan Y; Kim VJ; Engle SE; Berry JN; McIntosh JM; Neve RL; Drenan RM
Eur J Neurosci; 2019 Aug; 50(3):2224-2238. PubMed ID: 29779223
[TBL] [Abstract][Full Text] [Related]
2. Neuron-Specific Genome Modification in the Adult Rat Brain Using CRISPR-Cas9 Transgenic Rats.
Bäck S; Necarsulmer J; Whitaker LR; Coke LM; Koivula P; Heathward EJ; Fortuno LV; Zhang Y; Yeh CG; Baldwin HA; Spencer MD; Mejias-Aponte CA; Pickel J; Hoffman AF; Spivak CE; Lupica CR; Underhill SM; Amara SG; Domanskyi A; Anttila JE; Airavaara M; Hope BT; Hamra FK; Richie CT; Harvey BK
Neuron; 2019 Apr; 102(1):105-119.e8. PubMed ID: 30792150
[TBL] [Abstract][Full Text] [Related]
3. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
4. Multiplexed Gene Editing and Protein Overexpression Using a
Cody WB; Scholthof HB; Mirkov TE
Plant Physiol; 2017 Sep; 175(1):23-35. PubMed ID: 28663331
[TBL] [Abstract][Full Text] [Related]
5. α6-Containing nicotinic acetylcholine receptors in midbrain dopamine neurons are poised to govern dopamine-mediated behaviors and synaptic plasticity.
Berry JN; Engle SE; McIntosh JM; Drenan RM
Neuroscience; 2015 Sep; 304():161-75. PubMed ID: 26210579
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
Muramoto T; Iriki H; Watanabe J; Kawata T
Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
[TBL] [Abstract][Full Text] [Related]
7. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
Qiu Y; Ding Q
STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
[TBL] [Abstract][Full Text] [Related]
8. Generation of conditional Acvrl1 knockout mice by CRISPR/Cas9-mediated gene targeting.
Xu M; Xu H; Chen J; Chen C; Xu F; Qin Z
Mol Cell Probes; 2018 Feb; 37():32-38. PubMed ID: 29129659
[TBL] [Abstract][Full Text] [Related]
9. Construction of Viral Vectors for Cell Type-specific CRISPR Gene Editing in the Adult Mouse Brain.
Yamaguchi H; de Lecea L
Bio Protoc; 2019 Aug; 9(16):e3334. PubMed ID: 33654839
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific CRISPR-Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins.
Hoffmann MD; Aschenbrenner S; Grosse S; Rapti K; Domenger C; Fakhiri J; Mastel M; Börner K; Eils R; Grimm D; Niopek D
Nucleic Acids Res; 2019 Jul; 47(13):e75. PubMed ID: 30982889
[TBL] [Abstract][Full Text] [Related]
11. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
Lyu P; Javidi-Parsijani P; Atala A; Lu B
Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
[TBL] [Abstract][Full Text] [Related]
12. Manipulating the Biosynthesis of Bioactive Compound Alkaloids for Next-Generation Metabolic Engineering in Opium Poppy Using CRISPR-Cas 9 Genome Editing Technology.
Alagoz Y; Gurkok T; Zhang B; Unver T
Sci Rep; 2016 Aug; 6():30910. PubMed ID: 27483984
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
14. Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs.
Stahl EC; Sabo JK; Kang MH; Allen R; Applegate E; Kim SE; Kwon Y; Seth A; Lemus N; Salinas-Rios V; Soczek KM; Trinidad M; Vo LT; Jeans C; Wozniak A; Morris T; Kimberlin A; Foti T; Savage DF; Doudna JA
Mol Ther; 2023 Aug; 31(8):2422-2438. PubMed ID: 37403358
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
Kuruvilla J; Sasmita AO; Ling APK
Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
[TBL] [Abstract][Full Text] [Related]
16. Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice.
Zhu W; Saw D; Weiss M; Sun Z; Wei M; Shaligram S; Wang S; Su H
Transl Stroke Res; 2019 Oct; 10(5):557-565. PubMed ID: 30511203
[TBL] [Abstract][Full Text] [Related]
17. Changes in Nicotinic Neurotransmission during Enteric Nervous System Development.
Foong JP; Hirst CS; Hao MM; McKeown SJ; Boesmans W; Young HM; Bornstein JC; Vanden Berghe P
J Neurosci; 2015 May; 35(18):7106-15. PubMed ID: 25948261
[TBL] [Abstract][Full Text] [Related]
18. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo.
Ibraheim R; Tai PWL; Mir A; Javeed N; Wang J; Rodríguez TC; Namkung S; Nelson S; Khokhar ES; Mintzer E; Maitland S; Chen Z; Cao Y; Tsagkaraki E; Wolfe SA; Wang D; Pai AA; Xue W; Gao G; Sontheimer EJ
Nat Commun; 2021 Nov; 12(1):6267. PubMed ID: 34725353
[TBL] [Abstract][Full Text] [Related]
19. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line.
Chu VT; Graf R; Wirtz T; Weber T; Favret J; Li X; Petsch K; Tran NT; Sieweke MH; Berek C; Kühn R; Rajewsky K
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12514-12519. PubMed ID: 27729526
[TBL] [Abstract][Full Text] [Related]
20. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
